Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'C-ERBB-2 PROTEIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 145 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gaballah, HE; Salam, IA; Wahab, NA; Mansour, OM
      Plasma bcl-2 and nitric oxide - Possible prognostic role in patients with metastatic breast cancer

      MEDICAL ONCOLOGY
    2. Tsongalis, GJ; Ricci, A
      HER2: The Neu prognostic marker for breast cancer

      CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
    3. Climent, MA; Segui, MA; Peiro, G; Molina, R; Lerma, E; Ojeda, B; Lopez-Lopez, JJ; Alonso, C
      Prognostic value of HER-23/neu and p53 expression in node-positive breast cancer. HER-2/neu effect on adjuvant tamoxifen treatment

      BREAST
    4. Nicholson, RI; Gee, JMW; Harper, ME
      EGFR and cancer prognosis

      EUROPEAN JOURNAL OF CANCER
    5. Kazkayasi, M; Hucumenoglu, S; Siriner, GI; Hucumenoglu, M
      Over-expression of p53 and c-erbB-2 oncoproteins in laryngeal carcinoma

      EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
    6. Ross, JS; McKenna, BJ
      The HER-2/neu oncogene in tumors of the gastrointestinal tract

      CANCER INVESTIGATION
    7. Cook, GB; Neaman, IE; Goldblatt, JL; Cambetas, DR; Hussain, M; Luftner, D; Yeung, KK; Chan, DW; Schwartz, MK; Allard, WJ
      Clinical utility of scram HER-2/neu testing on the Bayer Immuno 1 (R) automated system in breast cancer

      ANTICANCER RESEARCH
    8. Suo, ZH; Bjaamer, A; Ottestad, L; Nesland, JM
      Expression of EGFR family and steroid hormone receptors in ductal carcinoma in situ of the breast

      ULTRASTRUCTURAL PATHOLOGY
    9. Yu, DH
      Mechanisms of ErbB2-mediated paclitaxel resistance and trastuzumab-mediated paclitaxel sensitization in ErbB2-overexpressing breast cancers

      SEMINARS IN ONCOLOGY
    10. Matsuo, K; Fukutomi, T; Tsuda, H; Akashi-Tanaka, S; Shimizu, C; Hasegawa, T
      Differences in estrogen receptor status, HER2, and p53 comparing metachronous bilateral breast carcinoma

      JOURNAL OF SURGICAL ONCOLOGY
    11. Ardizzoni, A; Cafferata, MA; Paganuzzi, M; Filiberti, R; Marroni, P; Neri, M; Fontana, V; Nicolo, G; Perdelli, L; Stampino, CG; Rosso, R; Puntoni, R
      Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma

      CANCER
    12. Leong, ASY; Sormunen, RT; Vinyuvat, S; Hamdani, RW; Suthipintawong, C
      Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma - A comparison of eight contemporary grading systems

      AJCP. American journal of clinical pathology
    13. Colomer, R; Montero, S; Lluch, A; Ojeda, B; Barnadas, A; Casado, A; Massuti, B; Cortes-Funes, H; Lloveras, B
      Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancer

      CLINICAL CANCER RESEARCH
    14. Kono, K; Naganuma, H; Sekikawa, T; Amemiya, H; Takahashi, A; Lizuka, H; Matsumoto, Y
      Serum level of HER-2/neu in patients with gastric cancer: Correlation withHER-2/neu overexpression in gastric carcinoma tissue

      TUMOR BIOLOGY
    15. Yu, DH; Hung, MC
      Overexpression of ErbB2 in cancer and ErbB2-targeting strategies

      ONCOGENE
    16. Zhang, SL; Schinella, R
      Expressions of ER, PR, Her2/neu and Ki-67 and their correlation in 55 cases of infiltrating ductal carcinoma of the breast

      JOURNAL OF TUMOR MARKER ONCOLOGY
    17. Guski, H; Hufnagl, P; Kaufmann, O; Krause, M; Winzer, KJ
      AgNOR analysis of atypical ductal hyperplasia and intraductal carcinoma ofthe breast

      ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
    18. Berry, DA; Muss, HB; Thor, AD; Dressler, L; Liu, ET; Broadwater, G; Budman, DR; Henderson, IC; Barcos, M; Hayes, D; Norton, L
      HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    19. Yu, DH; Hung, MC
      Role of erbB2 in breast cancer chemosensitivity

      BIOESSAYS
    20. Nicholson, BP
      Ongoing and planned trials of hormonal therapy and trastuzumab

      SEMINARS IN ONCOLOGY
    21. Durany, N; Joseph, J; Jimenez, OM; Climent, F; Fernandez, PL; Rivera, F; Carreras, J
      Phosphoglycerate mutase, 2,3 bisphosphoglycerate phosphatase, creatine kinase and enolase activity and isoenzymes in breast carcinoma

      BRITISH JOURNAL OF CANCER
    22. Lukas, J; Niu, N; Press, MF
      p53 mutations and expression in breast carcinoma in situ

      AMERICAN JOURNAL OF PATHOLOGY
    23. Lin, WC; Li, AFY; Chi, CW; Chung, WW; Huang, CL; Lui, WY; Kung, HJ; Wu, CW
      tie-1 protein tyrosine kinase: A novel independent prognostic marker for gastric cancer

      CLINICAL CANCER RESEARCH
    24. Srinivasan, R; Benton, E; McCormick, F; Thomas, H; Gullick, WJ
      Expression of the c-erbB-3/HER-3 and c-erbB-4/HER-4 growth factor receptors and their ligands, neuregulin-1 alpha, neuregulin-1 beta, and betacellulin, in normal endometrium and endometrial cancer

      CLINICAL CANCER RESEARCH
    25. Bhoola, S; DeRose, PB; Cohen, C
      Ductal carcinoma in situ of the breast: Frequency of biomarkers according to histologic subtype

      APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    26. Chamberlain, NL; Ward, RL; Hawkins, NJ
      Clinicopathological significance of erbB-2 expression in colorectal carcinoma

      ONCOLOGY REPORTS
    27. Wu, YY; Khan, H; Chillar, R; Vadgama, JV
      Prognostic value of plasma HER-2/neu in African American and Hispanic women with breast cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    28. Ngan, HYS; Liu, SS; Yu, H; Liu, KL; Cheung, ANY
      Proto-oncogenes and p53 protein expression in normal cervical stratified squamous epithelium and cervical intra-epithelial neoplasia

      EUROPEAN JOURNAL OF CANCER
    29. Pegram, M; Hsu, S; Lewis, G; Pietras, R; Beryt, M; Sliwkowski, M; Coombs, D; Baly, D; Kabbinavar, F; Slamon, D
      Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

      ONCOGENE
    30. Werkmeister, R; Fillies, T; Brandt, B; Groner, B; Wels, W; Joos, U
      Chemosensitivity testing of oral cancer cells treated with a p185(neu)-specific agent

      EUROPEAN JOURNAL OF ORAL SCIENCES
    31. Solomides, CC; Zimmerman, R; Bibbo, M
      Semiquantitative assessment of c-erbB-2 (HER-2) status in cytology specimens and tissue sections from breast carcinoma

      ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
    32. Iczkowski, KA; Shanks, JH; Allsbrook, WC; Lopez-Beltran, A; Pantazis, CG; Collins, TR; Wetherington, RW; Bostwick, DG
      Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression,a unique pattern of cytokeratin expression, and more intense gamma-enolaseexpression

      HISTOPATHOLOGY
    33. Hennig, EM; Kvinnsland, S; Holm, R; Nesland, JM
      Significant difference in p53 and p21 protein immunoreactivity in HPV 16 positive and HPV negative breast carcinomas

      ACTA ONCOLOGICA
    34. Yokota, T; Imamura, M; Teshima, S; Suzuki, H; Tezuka, F; Kikuchi, S; Kunii, Y; Yamauchi, H
      c-erba-2, p53 protein expression and steroid hormone receptors in breast carcinomas: An immunohistochemical study

      ANTICANCER RESEARCH
    35. Haussler, O; Epstein, JI; Amin, MB; Heitz, PU; Hailemariam, S
      Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer

      HUMAN PATHOLOGY
    36. Choi, JH; Kim, HC; Lim, HY; Nam, DK; Kim, HS; Yi, SY; Shim, KS; Han, WS
      Detection of transforming growth factor-alpha in the serum of gastric carcinoma patients

      ONCOLOGY
    37. Yeh, SY; Lin, HK; Kang, HY; Thin, TH; Lin, MF; Chang, CS
      From HER2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    38. Moore, E; Magee, H; Coyne, J; Gorey, T; Dervan, PA
      Widespread chromosomal abnormalities in high-grade ductal carcinoma in situ of the breast. Comparative genomic hybridization study of pure high-gradeDCIS

      JOURNAL OF PATHOLOGY
    39. Shimada, K; Ajani, JA
      Adjuvant therapy for gastric carcinoma patients in the past 15 years - A review of western and oriental trials

      CANCER
    40. LOMUZIO L; MIGNOGNA MD; FAVIA G; PROCACCINI M; TESTA NF; BUCCI E
      THE POSSIBLE ASSOCIATION BETWEEN ORAL LICHEN-PLANUS AND ORAL SQUAMOUS-CELL CARCINOMA - A CLINICAL-EVALUATION ON 14 CASES AND A REVIEW OF THE LITERATURE

      Oral Oncology
    41. TAKASAKI T; AKIBA S; SAGARA Y; YOSHIDA H
      HISTOLOGICAL AND BIOLOGICAL CHARACTERISTICS OF MICROINVASION IN MAMMARY CARCINOMAS LESS-THAN-OR-EQUAL-TO-2 CM IN DIAMETER

      Pathology international
    42. INOUE T; UCHINO S; SHIRAISHI N; ADACHI Y; KITANO S
      LOSS OF HETEROZYGOSITY ON CHROMOSOME 18Q IN COHESIVE-TYPE GASTRIC-CANCER IS ASSOCIATED WITH TUMOR PROGRESSION AND POOR-PROGNOSIS

      Clinical cancer research
    43. INOUE T; UCHINO S; SHIRAISHI N; ADACHI Y; KITANO S
      LOSS OF HETEROZYGOSITY ON CHROMOSOME 18Q IN COHESIVE-TYPE GASTRIC-CANCER IS ASSOCIATED WITH TUMOR PROGRESSION AND POOR-PROGNOSIS

      Clinical cancer research
    44. REVILLION F; BONNETERRE J; PEYRAT JP
      ERBB2 ONCOGENE IN HUMAN BREAST-CANCER AND ITS CLINICAL-SIGNIFICANCE

      European journal of cancer
    45. BRIEN TP; DEPOWSKI PL; SHEEHAN CE; ROSS JS; MCKENNA BJ
      PROGNOSTIC FACTORS IN GASTRIC-CANCER

      Modern pathology
    46. KALLAKURY BV; SHEEHAN CE; AMBROS RA; FISHER HA; KAUFMAN RP; MURACA PJ; ROSS JS
      CORRELATION OF P34(CDC2) CYCLIN-DEPENDENT KINASE OVEREXPRESSION, CD44S DOWN-REGULATION, AND HER-2 NEU ONCOGENE AMPLIFICATION WITH RECURRENCE IN PROSTATIC ADENOCARCINOMAS/

      Journal of clinical oncology
    47. ICZKOWSKI KA; SHANKS JH; BOSTWICK DG
      LOSS OF CD44 VARIANT-6 EXPRESSION DIFFERENTIATES SMALL-CELL CARCINOMAOF URINARY-BLADDER FROM UROTHELIAL (TRANSITIONAL-CELL) CARCINOMA

      Histopathology
    48. Suo, Z; Emilsen, E; Tveit, KM; Nesland, JM
      Type 1 protein tyrosine kinases in benign and malignant breast lesions

      HISTOPATHOLOGY
    49. BAST RC; PUSZTAI L; KERNS BJ; MACDONALD JA; JORDAN P; DALY L; BOYER CM; MENDELSOHN J; BERCHUCK A
      COEXPRESSION OF THE HER-2 GENE-PRODUCT, P185(HER-2), AND EPIDERMAL GROWTH-FACTOR RECEPTOR, P170(EGF-R), ON EPITHELIAL OVARIAN CANCERS AND NORMAL-TISSUES

      Hybridoma
    50. BETHWAITE P; SMITH N; DELAHUNT B; KENWRIGHT D
      REPRODUCIBILITY OF NEW CLASSIFICATION SCHEMES FOR THE PATHOLOGY OF DUCTAL CARCINOMA IN-SITU OF THE BREAST

      Journal of Clinical Pathology
    51. ZRIHANLICHT S; DENG BJ; YARDEN Y; MCSHAN G; KEYDAR I; AVRAHAM H
      CSK HOMOLOGOUS KINASE, A NOVEL SIGNALING MOLECULE, DIRECTLY ASSOCIATES WITH THE ACTIVATED ERBB-2 RECEPTOR IN BREAST-CANCER CELLS AND INHIBITS THEIR PROLIFERATION

      The Journal of biological chemistry
    52. JARVINEN TAH; HOLLI K; KUUKASJARVI T; ISOLA JJ
      PREDICTIVE VALUE OF TOPOISOMERASE II-ALPHA AND OTHER PROGNOSTIC FACTORS FOR EPIRUBICIN CHEMOTHERAPY IN ADVANCED BREAST-CANCER

      British Journal of Cancer
    53. Guerry, M; Vabre, L; Talbot, M; Mamelle, G; Leridant, AM; Hill, C; Bosq, J; Luboinski, B; Janot, F
      Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma: a case-control study

      BRITISH JOURNAL OF CANCER
    54. TAKAHASHI H; SASAKI S; OKAWA Y; TAGUCHI K; SASAKI F; UCHINO J; HATA Y; FUJITA M; NAGASHIMA K; ITO Y; KAWAI T
      CLINICAL-SIGNIFICANCE OF SERUM C-ERBB-2 PROTEIN IN PATIENTS WITH PRIMARY BREAST-CANCER

      Oncology Reports
    55. CADMAN BA; OSTROWSKI JL; QUINN CM
      INVASIVE DUCTAL CARCINOMA ACCOMPANIED BY DUCTAL CARCINOMA IN-SITU (DCIS) - COMPARISON OF DCIS GRADE WITH GRADE OF INVASIVE COMPONENT

      Breast
    56. CHOW NH; LIU HS; YANG HB; CHAN SH; SU IJ
      EXPRESSION PATTERNS OF ERBB RECEPTOR FAMILY IN NORMAL UROTHELIUM AND TRANSITIONAL-CELL CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY

      Virchows Archiv
    57. RIBEN MW; MALFETANO JH; NAZEER T; MURACA PJ; AMBROS RA; ROSS JS
      IDENTIFICATION OF HER-2 NEU ONCOGENE AMPLIFICATION BY FLUORESCENCE IN-SITU HYBRIDIZATION IN STAGE-I ENDOMETRIAL CARCINOMA/

      Modern pathology
    58. MORENO A; LLOVERAS B; FIGUERAS A; ESCOBEDO A; RAMON JM; SIERRA A; FABRA A
      DUCTAL CARCINOMA IN-SITU OF THE BREAST - CORRELATION BETWEEN HISTOLOGIC CLASSIFICATIONS AND BIOLOGIC MARKERS

      Modern pathology
    59. QUINN CM; OSTROWSKI JL; PARKIN GJS; HORGAN K; BENSON EA
      DUCTAL CARCINOMA IN-SITU OF THE BREAST - THE CLINICAL-SIGNIFICANCE OFHISTOLOGICAL CLASSIFICATION

      Histopathology
    60. BODEY B; BODEY B; GROGER AM; LUCK JV; SIEGEL SE; TAYLOR CR; KAISER HE
      CLINICAL AND PROGNOSTIC-SIGNIFICANCE OF THE EXPRESSION OF THE C-ERBB-2 AND C-ERBB-3 ONCOPROTEINS IN PRIMARY AND METASTATIC MALIGNANT MELANOMAS AND BREAST CARCINOMAS

      Anticancer research
    61. WALKER RA; JONES JL; CHAPPELL S; WALSH T; SHAW JA
      MOLECULAR PATHOLOGY OF BREAST-CANCER AND ITS APPLICATION TO CLINICAL MANAGEMENT

      Cancer metastasis reviews
    62. SCHNITT SJ; CONNOLLY JL
      CLASSIFICATION OF DUCTAL CARCINOMA IN-SITU - STRIVING FOR CLINICAL RELEVANCE IN THE ERA OF BREAST-CONSERVING THERAPY

      Human pathology
    63. MACK L; KERKVLIET N; DOIG G; OMALLEY FP
      RELATIONSHIP OF A NEW HISTOLOGICAL CATEGORIZATION OF DUCTAL CARCINOMAIN-SITU OF THE BREAST WITH SIZE AND THE IMMUNOHISTOCHEMICAL EXPRESSION OF P53, C-ERB B2, BCL-2, AND KI-67

      Human pathology
    64. ROSS JS; SHEEHAN C; HAYNERBUCHAN AM; AMBROS RA; KALLAKURY BVS; KAUFMAN R; FISHER HAG; MURACA PJ
      HER-2 NEU GENE AMPLIFICATION STATUS IN PROSTATE-CANCER BY FLUORESCENCE IN-SITU HYBRIDIZATION/

      Human pathology
    65. ENGELS K; FOX SB; WHITEHOUSE RM; GATTER KC; HARRIS AL
      DISTINCT ANGIOGENIC PATTERNS ARE ASSOCIATED WITH HIGH-GRADE IN-SITU DUCTAL CARCINOMAS OF THE BREAST

      Journal of pathology
    66. QUINN CM; OSTROWSKI JL
      CYTOLOGICAL AND ARCHITECTURAL HETEROGENEITY IN DUCTAL CARCINOMA IN-SITU OF THE BREAST

      Journal of Clinical Pathology
    67. GUPTA SK; DOUGLASJONES AG; FENN N; MORGAN JM; MANSEL RE
      THE CLINICAL BEHAVIOR OF BREAST-CARCINOMA IS PROBABLY DETERMINED AT THE PREINVASIVE STAGE (DUCTAL CARCINOMA IN-SITU)

      Cancer
    68. CHOI JH; OH JY; RYU SK; KIM SJ; LEE NY; KIM YS; YI SY; SHIM KS; HAN WS
      DETECTION OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN THE SERUM OF GASTRIC-CARCINOMA PATIENTS

      Cancer
    69. DIEZ M; POLLAN M; MAESTRO M; TORRES A; ORTEGA D; GOMEZ A; SANCHEZ A; HERNANDO F; BALIBREA JL
      PREDICTION OF RECURRENCE BY QUANTIFICATION OF P185(NEU) PROTEIN IN NON-SMALL-CELL LUNG-CANCER TISSUE

      British Journal of Cancer
    70. KESHGEGIAN AA; CNAAN A
      ERBB-2 ONCOPROTEIN EXPRESSION IN BREAST-CARCINOMA - POOR-PROGNOSIS ASSOCIATED WITH HIGH-DEGREE OF CYTOPLASMIC POSITIVITY USING CB-11 ANTIBODY

      American journal of clinical pathology
    71. GALE N; ZIDAR N; KAMBIC V; POLJAK M; COR A
      EPIDERMAL GROWTH-FACTOR RECEPTOR, C-ERBB-2 AND P53 OVEREXPRESSIONS INEPITHELIAL HYPERPLASTIC LESIONS OF THE LARYNX

      Acta oto-laryngologica
    72. LUZAR B; GALE N; KAMBIC V; POLJAK M; ZIDAR N; VODOVNIK A
      HUMAN PAPILLOMAVIRUS INFECTION AND EXPRESSION OF P53 AND C-ERBB-2 PROTEIN IN LARYNGEAL PAPILLOMAS

      Acta oto-laryngologica
    73. SILVESTRINI R; VENERONI S; BENINI E; DAIDONE MG; LUISI A; LEUTNER M; MAUCIONE A; KENDA R; ZUCALI R; VERONESI U
      EXPRESSION OF P53, GLUTATHIONE-S-TRANSFERASE-PI, AND BCL-2 PROTEINS AND BENEFIT FROM ADJUVANT RADIOTHERAPY IN BREAST-CANCER

      Journal of the National Cancer Institute
    74. WEBB A; SCOTTMACKIE P; CUNNINGHAM D; NORMAN A; ANDREYEV J; OBRIEN M; BENSTED J
      THE PROGNOSTIC VALUE OF SERUM AND IMMUNOHISTOCHEMICAL TUMOR-MARKERS IN ADVANCED GASTRIC-CANCER

      European journal of cancer
    75. HASEBE T; TSUDA H; HIROHASHI S; SHIMOSATO Y; IWAI M; IMOTO S; MUKAI K
      FIBROTIC FOCUS IN INVASIVE DUCTAL CARCINOMA - AN INDICATOR OF HIGH TUMOR AGGRESSIVENESS

      Japanese journal of cancer research
    76. DOUGLASJONES AG; GUPTA SK; ATTANOOS RL; MORGAN JM; MANSEL RE
      A CRITICAL-APPRAISAL OF 6 MODERN CLASSIFICATIONS OF DUCTAL CARCINOMA IN-SITU OF THE BREAST (DCIS) - CORRELATION WITH GRADE OF ASSOCIATED INVASIVE-CARCINOMA

      Histopathology
    77. NIELSEN AL; NYHOLM HCJ
      THE COMBINATION OF P53 AND AGE PREDICT CANCER SPECIFIC DEATH IN ADVANCED-STAGE (FIGO IC-IV) OF ENDOMETRIAL CARCINOMA OF ENDOMETRIOID TYPE -AN IMMUNOHISTOCHEMICAL EXAMINATION OF GROWTH FRACTION, KI-67, MIB-1 AND PC10 SUPPRESSOR ONCOGENE PROTEIN, P53 ONCOGENE PROTEIN, P185 AND AGE, HORMONE-TREATMENT, STAGE, AND HISTOLOGIC GRADE

      European journal of obstetrics, gynecology, and reproductive biology
    78. CARUSO ML; VALENTINI AM
      IMMUNOHISTOCHEMICAL P53 OVEREXPRESSION CORRELATED TO C-ERBB-2 AND CATHEPSIN-D PROTEINS IN COLORECTAL-CANCER

      Anticancer research
    79. NAUNDORF H; PARCZYK K; ZSCHIESCHE W; REINECKE S; BUTTNER B; SAUL GJ; SINN B; FICHTNER I
      RELATION OF ESTRADIOL-MEDIATED GROWTH-STIMULATION WITH THE EXPRESSIONOF C-ERBB-2 PROTEIN IN XENOTRANSPLANTED ESTRADIOL-RECEPTOR-POSITIVE AND ESTRADIOL-RECEPTOR-NEGATIVE BREAST CARCINOMAS

      Journal of cancer research and clinical oncology
    80. WOOD WC
      MANAGEMENT OF LOBULAR CARCINOMA IN-SITU AND DUCTAL CARCINOMA IN-SITU OF THE BREAST

      Seminars in oncology
    81. NIIKURA H; SASANO H; KAGA K; SATO S; YAJIMA A
      EXPRESSION OF EPIDERMAL GROWTH-FACTOR FAMILY PROTEINS AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN HUMAN ENDOMETRIUM

      Human pathology
    82. LEE HR; KIM JH; UHM HD; AHN JB; RHA SY; CHO JY; LEE JI; LEE KH; CHUNG HC; ROH JK; MIN JS; LEE KS; SHIN DH; KIM BS; KIM BS; HONG SW; CHOI JH
      OVEREXPRESSION OF C-ERBB-2 PROTEIN IN GASTRIC-CANCER BY IMMUNOHISTOCHEMICAL STAIN

      Oncology
    83. GOLDSTONE AR; QUIRKE P; DIXON MF
      HELICOBACTER-PYLORI INFECTION AND GASTRIC-CANCER

      Journal of pathology
    84. TSAI CM; CHANG KT; WU LH; CHEN JY; GAZDAR AF; MITSUDOMI T; CHEN MH; PERNGPERNG R
      CORRELATIONS BETWEEN INTRINSIC CHEMORESISTANCE AND HER-2 NEU GENE-EXPRESSION, P53 GENE-MUTATIONS, AND CELL-PROLIFERATION CHARACTERISTICS INNON-SMALL-CELL LUNG-CANCER CELL-LINES/

      Cancer research
    85. SANFILIPPO JS; MISELJIC S; YANG AR; DOERING DL; SHAHEEN RM; WITTLIFF JL
      QUANTITATIVE-ANALYSES OF EPIDERMAL GROWTH-FACTOR RECEPTORS, HER-2 NEUONCOPROTEIN AND CATHEPSIN-D IN NONMALIGNANT AND MALIGNANT UTERI/

      Cancer
    86. BOSE S; LESSER ML; NORTON L; ROSEN PP
      IMMUNOPHENOTYPE OF INTRADUCTAL CARCINOMA

      Archives of pathology and laboratory medicine
    87. GOLDSTEIN NS; MURPHY T
      INTRADUCTAL CARCINOMA-ASSOCIATED WITH INVASIVE-CARCINOMA OF THE BREAST - A COMPARISON OF THE 2 LESIONS WITH IMPLICATIONS FOR INTRADUCTAL CARCINOMA CLASSIFICATION SYSTEMS

      American journal of clinical pathology
    88. LEONG ASY; LEE AKC
      BIOLOGICAL INDEXES IN THE ASSESSMENT OF BREAST-CANCER

      JCP. Clinical molecular pathology
    89. GASPARINI G; BARBARESCHI M; DOGLIONI C; PALMA PD; MAURI FA; BORACCHI P; BEVILACQUA P; CAFFO O; MORELLI L; VERDERIO P; PEZZELLA F; HARRIS AL
      EXPRESSION OF BCL-2 PROTEIN PREDICTS EFFICACY OF ADJUVANT TREATMENTS IN OPERABLE NODE-POSITIVE BREAST-CANCER

      Clinical cancer research
    90. LONN U; LONN S; FRIBERG S; NILSSON B; SILFVERSWARD C; STENKVIST B
      PROGNOSTIC VALUE OF AMPLIFICATION OF C-ERB-B2 IN BLADDER-CARCINOMA

      Clinical cancer research
    91. WU JT; ASTILL ME; GAGON SD; BRYSON L
      MEASUREMENT OF C-ERBB-2 PROTEINS IN SERA FROM PATIENTS WITH CARCINOMAS AND IN BREAST-TUMOR TISSUE CYTOSOLS - CORRELATION WITH SERUM TUMOR-MARKERS AND MEMBRANE-BOUND ONCOPROTEIN

      Journal of clinical laboratory analysis
    92. BERNS EMJJ; FOEKENS JA; VANSTAVEREN IL; VANPUTTEN WLJ; DEKONING HYWCM; PORTENGEN H; KLIJN JGM
      ONCOGENE AMPLIFICATION AND PROGNOSIS IN BREAST-CANCER - RELATIONSHIP WITH SYSTEMIC TREATMENT

      Gene
    93. AJANI JA; MANSFIELD PF; OTA DM
      POTENTIALLY RESECTABLE GASTRIC-CARCINOMA - CURRENT APPROACHES TO STAGING AND PREOPERATIVE THERAPY

      World journal of surgery
    94. NAGASHIMA M; TSUDA H; TAKENOSHITA S; NAGAMACHI Y; HIROHASHI S; YOKOTA J; KASAI H
      8-HYDROXYDEOXYGUANOSINE LEVELS IN DNA OF HUMAN BREAST CANCERS ARE NOTSIGNIFICANTLY DIFFERENT FROM THOSE OF NON-CANCEROUS BREAST TISSUES BYTHE HPLC-ECD METHOD

      Cancer letters
    95. NIELSEN AL; NYHOLM HCJ
      ENDOMETRIAL ADENOCARCINOMA OF ENDOMETRIOID SUBTYPE WITH SQUAMOUS DIFFERENTIATION - AN IMMUNOHISTOCHEMICAL STUDY OF MIB-1 (KI-67 PARAFFIN), CATHEPSIN-D, AND C-ERBB-2 PROTEIN (P185)

      International journal of gynecological pathology
    96. NASU K; HAYATA T; TAKAI N; KAWANO Y; SUGANO T; MATSUI N; MIYAKAWA I
      IMMUNOHISTOCHEMICAL STUDY OF C-ERB B-2 PROTEIN EXPRESSION IN ENDOMETRIOSIS

      Human reproduction
    97. SAUTER G; MOCH H; GASSER TC; MIHATSCH MJ; WALDMAN FM
      HETEROGENEITY OF CHROMOSOME-17 AND ERBB-2 GENE COPY NUMBER IN PRIMARYAND METASTATIC BLADDER-CANCER

      Cytometry
    98. BEVILACQUA P; BARBARESCHI M; VERDERIO P; BORACCHI P; CAFFO O; DALLAPALMA P; MELI S; WEIDNER N; GASPARINI G
      PROGNOSTIC VALUE OF INTRATUMORAL MICROVESSEL DENSITY, A MEASURE OF TUMOR ANGIOGENESIS, IN NODE-NEGATIVE BREAST-CARCINOMA - RESULTS OF A MULTIPARAMETRIC STUDY

      Breast cancer research and treatment
    99. KESHGEGIAN AA
      ERBB-2 ONCOPROTEIN OVEREXPRESSION IN BREAST-CARCINOMA - INVERSE CORRELATION WITH BIOCHEMICALLY-DETERMINED AND IMMUNOHISTOCHEMICALLY-DETERMINED HORMONE RECEPTORS

      Breast cancer research and treatment
    100. NIIKURA H; SASANO H; MATSUNAGA G; WATANABE K; ITO K; SATO S; YAJIMA A
      PROGNOSTIC VALUE OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN ENDOMETRIOID ENDOMETRIAL CARCINOMA

      Human pathology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 11:45:36